Ilika commercial demand is very strong (LON:IKA)
19 July 2022
BioNTech SE (NASDAQ: BNTX), a recognized leader in biotechnology based in Germany, has been making waves in the healthcare sector with its pioneering work in immunotherapy and mRNA technology. With..
HealthEquity, Inc. (NASDAQ: HQY), a leader in the Health Information Services industry, is capturing investor attention with its promising growth potential and dominant position in the healthcare sector. With a..
Henry Schein, Inc. (NASDAQ: HSIC), a stalwart in the healthcare sector, is capturing investor attention with its robust market position and potential for a 14.17% upside. As a leading provider..
Biogen Inc. (BIIB), a prominent player in the healthcare sector, stands out in the drug manufacturing industry despite facing recent headwinds. With a market capitalization of $26.03 billion, Biogen is..
Avantor, Inc. (NYSE: AVTR), a prominent player in the healthcare sector, is capturing investor attention with its potential upside of 24.14%, as suggested by analysts’ target prices. This potential growth..
Investors looking to explore opportunities in the healthcare sector might find Chemed Corp (NYSE: CHE) an intriguing prospect. With its diverse business operations spanning hospice care and plumbing services, Chemed..
Summit Therapeutics Inc. (NASDAQ: SMMT) has caught the attention of investors in the biotech sector, thanks to its promising pipeline and potential upside of 23.70%. Let’s delve into the various..
For investors with an eye on the healthcare sector, Stevanato Group S.p.A. (NYSE: STVN) offers a compelling opportunity. With its strategic position in the medical instruments and supplies industry, this..
Regencell Bioscience Holdings Limited (NASDAQ: RGC), a Hong Kong-based company specializing in Traditional Chinese Medicine (TCM), has captured the attention of investors with its dramatic 52-week price range spanning from..
Bio-Rad Laboratories, Inc. (NYSE: BIO) stands as a prominent figure in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $8.07 billion, this American-based company..
Illumina, Inc. (NASDAQ: ILMN) stands at the forefront of genomic innovation, providing sequencing and array-based solutions that are pivotal for genetic and genomic analysis across the globe. With a market..
Charles River Laboratories International, Inc. (CRL) has long been a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Boasting a market capitalization of $9.07 billion,..
Alcon Inc. (NYSE: ALC), a leading player in the healthcare sector, particularly in the medical instruments and supplies industry, presents a compelling opportunity for investors with its robust market presence..
Veeva Systems Inc. (NYSE: VEEV) stands as a formidable force in the health information services industry, known for its innovative cloud-based solutions catering to the life sciences sector. With a..
Investors with a keen eye on the biotechnology sector are likely to find Revolution Medicines, Inc. (NASDAQ: RVMD) a compelling prospect. Headquartered in Redwood City, California, this clinical-stage precision oncology..
Hologic, Inc. (NASDAQ: HOLX) stands as a notable player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $16.97 billion, Hologic has..
Doximity, Inc. (NYSE: DOCS), a leading player in the healthcare information services industry, presents an intriguing opportunity for investors seeking exposure in the digital health sector. With a market capitalization..
For investors looking to expand their portfolios in the healthcare sector, Qiagen N.V. (NYSE: QGEN) offers a compelling opportunity with significant growth potential. Headquartered in Venlo, Netherlands, Qiagen is a..
Bio-Techne Corp (NASDAQ: TECH), a prominent player in the biotechnology sector, is drawing significant attention from investors due to its promising potential upside of 22.02%. As a leader in developing..
Incyte Corporation (NASDAQ: INCY) continues to capture the attention of investors with its robust portfolio in the biopharmaceutical space. With a market capitalization of $19.47 billion, Incyte is a prominent..
